Medulloblastoma comprises four distinct molecular variants

Journal of Clinical Oncology

Volumn 29, Issue 11, 2011, Pages 1408-1414

  Northcott, Paul A ^{a,b,c,d,e,f,g}   Korshunov, Andrey ^{a,b,c,d,e,f,g}   Witt, Hendrik ^{a,b,c,d,e,f,g}   Hielscher, Thomas ^{a,b,c,d,e,f,g}   Eberhart, Charles G ^{a,b,c,d,e,f,g}   Mack, Stephen ^{a,b,c,d,e,f,g}   Bouffet, Eric ^{a,b,c,d,e,f,g}   Clifford, Steven C ^{a,b,c,d,e,f,g}   Hawkins, Cynthia E ^{a,b,c,d,e,f,g}   French, Pim ^{a,b,c,d,e,f,g}   Rutka, James T ^{a,b,c,d,e,f,g}   Pfister, Stefan ^{a,b,c,d,e,f,g}   Taylor, Michael D ^{a,b,c,d,e,f,g}  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; MESSENGER RNA; NPR3 PROTEIN; POTASSIUM CHANNEL KV1.1; PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BIOINFORMATICS; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENDER; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; METASTASIS; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SCHOOL CHILD; TISSUE MICROARRAY; TUMOR CLASSIFICATION; TUMOR GENE;

ANALYSIS OF VARIANCE; BETA CATENIN; CEREBELLAR NEOPLASMS; CHILD; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KV1.1 POTASSIUM CHANNEL; MEDULLOBLASTOMA; MEMBRANE PROTEINS; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION; SOFTWARE; SURVIVAL RATE; TRANSCRIPTION, GENETIC;

EID: 79955034739     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.4324     Document Type: Article

References (35)

1. Ray A, Ho M, Ma J, et al: A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10:7613-7620, 2004 (Pubitemid 39557524)
2. Gilbertson RJ, Perry RH, Kelly PJ, et al: Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res 57:3272-3280, 1997 (Pubitemid 27351746)
3. Grotzer MA, Janss AJ, Fung K, et al: TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 18:1027-1035, 2000 (Pubitemid 30123779)
4. Clifford SC, Lusher ME, Lindsey JC, et al: Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 5:2666-2670, 2006
5. Ellison DW, Onilude OE, Lindsey JC, et al: Beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23:7951-7957, 2005 (Pubitemid 46657395)
6. Pfister S, Remke M, Benner A, et al: Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 27:1627-1636, 2009
7. Grotzer MA, Hogarty MD, Janss AJ, et al: MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res 7:2425-2433, 2001 (Pubitemid 32751645)
8. Gajjar A, Hernan R, Kocak M, et al: Clinical, histopathologic, and molecular markers of prognosis: Toward a new disease risk stratification system for medulloblastoma. J Clin Oncol 22:984-993, 2004 (Pubitemid 41095029)
9. Gilbertson R, Wickramasinghe C, Hernan R, et al: Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer 85:705-712, 2001 (Pubitemid 32929469)
10. Pan E, Pellarin M, Holmes E, et al: Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Clin Cancer Res 11:4733-4740, 2005 (Pubitemid 41557192)
11. Northcott PA, Nakahara Y, Wu X, et al: Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 41:465-472, 2009
12. Northcott PA, Fernandez LA, Hagan JP, et al: The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 69:3249-3255, 2009
13. Neben K, Korshunov A, Benner A, et al: Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res 64:3103-3111, 2004 (Pubitemid 38581410)
14. Eberhart CG, Chaudhry A, Daniel RW, et al: Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus. BMC Cancer 5:19, 2005
15. Tibshirani R, Hastie T, Narasimhan B, et al: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99:6567-6572, 2002 (Pubitemid 34526173)
16. Kool M, Koster J, Bunt J, et al: Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3:e3088, 2008
17. Subramanian A, Tamayo P, Mootha VK, et al: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550, 2005 (Pubitemid 41528093)
18. Mootha VK, Lindgren CM, Eriksson KF, et al: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273, 2003 (Pubitemid 36792858)
19. Brunet JP, Tamayo P, Golub TR, et al: Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci U S A 101:4164-4169, 2004 (Pubitemid 38405900)
20. Hoshida Y, Brunet JP, Tamayo P, et al: Subclass mapping: Identifying common subtypes in independent disease data sets. PLoS One 2:e1195, 2007
21. McManamy CS, Pears J, Weston CL, et al: Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol 17:151-164, 2007 (Pubitemid 46466135)
22. Boon K, Eberhart CG, Riggins GJ: Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Cancer Res 65:703-707, 2005 (Pubitemid 40216425)
23. Di C, Liao S, Adamson DC, et al: Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res 65:919-924, 2005 (Pubitemid 40216452)
24. Adesina AM, Nguyen Y, Mehta V, et al: FOXG1 dysregulation is a frequent event in medulloblastoma. J Neurooncol 85:111-122, 2007 (Pubitemid 47629393)
25. Fattet S, Haberler C, Legoix P, et al: Betacatenin status in paediatric medulloblastomas: Correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol 218:86-94, 2009
26. Thompson MC, Fuller C, Hogg TL, et al: Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24:1924-1931, 2006 (Pubitemid 46638992)
27. Hubert L, Arabie P: Comparing partitions. J Classif 2:193-218, 1985
28. Pomeroy SL, Tamayo P, Gaasenbeek M, et al: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442, 2002 (Pubitemid 34100955)
29. Beroukhim R, Getz G, Nghiemphu L, et al: Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci U S A 104:20007-20012, 2007
30. Tabori U, Sung L, Hukin J, et al: Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma. Int J Radiat Oncol Biol Phys 64:402-407, 2006 (Pubitemid 43083425)
31. Gajjar A, Chintagumpala M, Ashley D, et al: Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 7:813-820, 2006 (Pubitemid 44464063)
32. Curran EK, Sainani KL, Le GM, et al: Gender affects survival for medulloblastoma only in older children and adults: A study from the Surveillance Epidemiology and End Results Registry. Pediatr Blood Cancer 52:60-64, 2009
33. Rutkowski S, Gerber NU, von Hoff K, et al: Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro Oncol 11:201-210, 2009
34. Judkins AR, Mauger J, Ht A, et al: Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644-650, 2004 (Pubitemid 38579568)
35. Biegel JA, Zhou JY, Rorke LB, et al: Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74-79, 1999 (Pubitemid 29062960)